Artiva Biotherapeutics, Inc.
ARTV
$10.79
-$0.09-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -90.82M | -87.07M | -83.87M | -79.19M | -75.13M |
| Total Depreciation and Amortization | 2.69M | 2.64M | 2.60M | 2.55M | 2.51M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.72M | 5.01M | 4.94M | 4.79M | 5.74M |
| Change in Net Operating Assets | 7.19M | 1.57M | -424.00K | -4.82M | -2.20M |
| Cash from Operations | -75.23M | -77.86M | -76.75M | -76.68M | -69.09M |
| Capital Expenditure | -1.68M | -2.32M | -2.59M | -2.23M | -1.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.90M | 71.07M | 66.00M | 48.64M | -98.78M |
| Cash from Investing | 65.22M | 68.76M | 63.41M | 46.41M | -100.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -111.00K | -132.00K | -132.00K | -131.00K | -137.00K |
| Issuance of Common Stock | 300.21M | 134.00K | 272.00K | 295.00K | 166.81M |
| Repurchase of Common Stock | -535.00K | -574.00K | -364.00K | -277.00K | -39.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.56M | 230.00K | 233.00K | 213.00K | -2.62M |
| Cash from Financing | 283.00M | -342.00K | 9.00K | 100.00K | 164.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 272.99M | -9.45M | -13.33M | -30.17M | -5.58M |